Literature DB >> 33602083

Phyto-Compounds from a Rather Poisonous Plant, Strychnos nuxvomica, Show High Potency Against SARS-CoV-2 RNA-Dependent RNA Polymerase.

Acharya Balkrishna1,2, Subarna Pokhrel1, Anurag Varshney1,2.   

Abstract

BACKGROUND: The establishment of strategy to inhibit the virus replication is an attractive means in combating SARS-CoV-2 infection.
OBJECTIVE: We studied phyto-compounds from Strychnos nux-vomica (a poisonous plant) against SARS-CoV-2 RNA-dependent RNA polymerase by computational methods.
METHODS: Molecular docking, molecular dynamics (MD) simulation and energetics calculations were employed to elucidate the role of the phyto-compounds.
RESULTS: Ergotamine with a binding free energy of -14.39 kcal/mol showed a promising capability in terms of binding affinity and the interaction to conserved motifs, especially the SDD signature sequence. The calculated dissociation constants for ATP, ergotamine, isosungucine and sungucine were 12 μM, 0.072 nM, 0.011 nM and 0.152 nM, respectively. The exhibited kd by these phyto-compounds reflected tens of thousands fold potency as compared to ATP. The binding free energies of sungucine and isosungucine were much lower (-13.93 and -15.55 kcal/mol, respectively) compared to that of ATP (-6.98 kcal/mol).
CONCLUSION: Sharing the same binding location as that of ATP and having high binding affinities, Ergotamine, Isosungucine, Sungucine and Strychnine N-oxide could be effective in controlling the SARS-CoV-2 virus replication by blocking the ATP and inhibiting the enzyme function. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  RNA-dependent RNA polymerase; SARS-CoV-2; Strychnos nux-vomica; computational methods; inhibition; phyto-compounds

Mesh:

Substances:

Year:  2022        PMID: 33602083     DOI: 10.2174/1566524021666210218113409

Source DB:  PubMed          Journal:  Curr Mol Med        ISSN: 1566-5240            Impact factor:   2.616


  2 in total

1.  Bisacodyl Limits Chikungunya Virus Replication In Vitro and Is Broadly Antiviral.

Authors:  Natalie J LoMascolo; Yazmin E Cruz-Pulido; Bryan C Mounce
Journal:  Antimicrob Agents Chemother       Date:  2022-06-02       Impact factor: 5.938

2.  In Silico Screening of Novel TMPRSS2 Inhibitors for Treatment of COVID-19.

Authors:  Shuo Wang; Xuexun Fang; Ye Wang
Journal:  Molecules       Date:  2022-06-30       Impact factor: 4.927

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.